Risk factors for intensive care admission in patients with COVID-19 pneumonia: A retrospective study

• DOI: 10.1016/j.jiph.2023.05.027
• Publication Date: 2023-05-25T00:49:52Z
• Authors: Abdullah Mobeireek; Saud AlSaleh; Loui Ezzat; Osama Al-saghier; Sultan Al-Amro; Abdulla Al-Jebreen; Armen Torchyan; Mohammed AlHajji; Liju Ahmed
• Keywords: Dyslipidemia

Coronavirus disease 2019 (COVID-19)-associated mortality is predominantly due to respiratory failure. However, risk factors and predictive models for progression in patients with COVID-19 are not consistent across the globe. In this study, we aimed assess associated intensive care (ICU) admission pneumonia. Information was retrieved from database of all admitted pneumonia between March 2020 July at a tertiary center Saudi Arabia. The patients’ demographic, clinical, laboratory radiological characteristics were analyzed. Of 1054 PCR proven COVID-19, 254 (24%) evidence enrolled. median age 55, 25.6% above 65 years 55.1% males. comorbidities included hypertension (45%), diabetes (43%), dyslipidemia (24%), solid organ bone marrow transplantation (14.5%), malignancy (13.4%), ischemic heart (10.6%) chronic kidney (9.4%). rate 4.7%, 22.8% ICU. ICU were> (RR: 1.74, CI 95%, 1.10–2.74, p = 0.017), melitus 1.66, 95% 1.06–2.62, 0.028), failure 2.51, 1.28–4.93, 0.007), rate> 25 2.75, 1.66–4.55, < 0.001), upper lobe involvement 1.68, 1.02–2.77, 0.043), C-reactive protein (CRP)> 140 1.89, 1.14–3.13, 0.013). 5.82, 1.81–18.68, 0.003), on chest radiography (RR:4.40, 1.22–15.86, 0.016), diffuse computed tomography changes 7.36, 2.31–23.46, 0.011), 4.20, 1.36–13.04, 6.85, 2.35–19.90, cerebrovascular (RR:13.61, 5.01–36.96 3.94, 1.32–11.78 0.023), oxygen saturation< 90% 12.19, 3.71–40.01, thrombocytopenia (RR:4.16, 1.37–12.64, 0.013), elevated troponin 6.20, 1.73–22.24, 0.003). nearly quarter required care. We identified several that may be useful predicting, triaging, managing patients. these findings need validated prospectively.